233 related articles for article (PubMed ID: 24763982)
1. A retrospective review of 126 high-grade neuroendocrine carcinomas of the colon and rectum.
Smith JD; Reidy DL; Goodman KA; Shia J; Nash GM
Ann Surg Oncol; 2014 Sep; 21(9):2956-62. PubMed ID: 24763982
[TBL] [Abstract][Full Text] [Related]
2. Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy.
Fields AC; Lu P; Vierra BM; Hu F; Irani J; Bleday R; Goldberg JE; Nash GM; Melnitchouk N
Ann Surg Oncol; 2019 Apr; 26(4):1127-1133. PubMed ID: 30706232
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine carcinomas of the colon and rectum.
Bernick PE; Klimstra DS; Shia J; Minsky B; Saltz L; Shi W; Thaler H; Guillem J; Paty P; Cohen AM; Wong WD
Dis Colon Rectum; 2004 Feb; 47(2):163-9. PubMed ID: 15043285
[TBL] [Abstract][Full Text] [Related]
4. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
Shafqat H; Ali S; Salhab M; Olszewski AJ
Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
[TBL] [Abstract][Full Text] [Related]
6. Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors.
Folkert IW; Sinnamon AJ; Concors SJ; Bennett BJ; Fraker DL; Mahmoud NN; Metz DC; Stashek KM; Roses RE
Ann Surg Oncol; 2020 Mar; 27(3):855-863. PubMed ID: 31701298
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience.
Saclarides TJ; Szeluga D; Staren ED
Dis Colon Rectum; 1994 Jul; 37(7):635-42. PubMed ID: 8026228
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
[TBL] [Abstract][Full Text] [Related]
9. Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canal.
Aytac E; Ozdemir Y; Ozuner G
J Visc Surg; 2014 Feb; 151(1):3-7. PubMed ID: 24412088
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine tumors of the colon and rectum: prognostic relevance and comparative performance of current staging systems.
Chagpar R; Chiang YJ; Xing Y; Cormier JN; Feig BW; Rashid A; Chang GJ; You YN
Ann Surg Oncol; 2013 Apr; 20(4):1170-8. PubMed ID: 23212760
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic analysis of colon and rectal neuroendocrine neoplasm in different stages].
Huang YT; Jia R; Xu Q; Ji SJ; Cui HT; Xu JM
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):146-151. PubMed ID: 30862146
[No Abstract] [Full Text] [Related]
13. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.
Miyamoto Y; Hayashi N; Sakamoto Y; Ohuchi M; Tokunagam R; Kurashige J; Hiyoshi Y; Baba Y; Iwagami S; Yoshida N; Yoshida M; Baba H
Int J Clin Oncol; 2015 Dec; 20(6):1140-6. PubMed ID: 25947545
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
[TBL] [Abstract][Full Text] [Related]
15. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas.
Larsen SG; Wiig JN; Giercksky KE
Am J Surg; 2005 Jul; 190(1):55-60. PubMed ID: 15972173
[TBL] [Abstract][Full Text] [Related]
16. Renal Neuroendocrine Neoplasms: A Single-center Experience.
McGarrah PW; Westin GFM; Hobday TJ; Scales JA; Ingimarsson JP; Leibovich BC; Halfdanarson TR
Clin Genitourin Cancer; 2020 Aug; 18(4):e343-e349. PubMed ID: 31911122
[TBL] [Abstract][Full Text] [Related]
17. High-grade Neuroendocrine Carcinomas of the Vulva: A Clinicopathologic Study of 16 Cases.
Chen PP; Ramalingam P; Alvarado-Cabrero I; Euscher ED; Nagarajan P; Lawson BC; Malpica A
Am J Surg Pathol; 2021 Mar; 45(3):304-316. PubMed ID: 32826525
[TBL] [Abstract][Full Text] [Related]
18. Liver-directed therapy for neuroendocrine neoplasm hepatic metastasis prolongs survival following progression after initial surgery.
Saxena A; Chua TC; Zhao J; Morris DL
J Surg Oncol; 2012 Mar; 105(4):342-50. PubMed ID: 22006355
[TBL] [Abstract][Full Text] [Related]
19. Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma.
Cusack JC; Giacco GG; Cleary K; Davidson BS; Izzo F; Skibber J; Yen J; Curley SA
J Am Coll Surg; 1996 Aug; 183(2):105-12. PubMed ID: 8696540
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic management and outcome of locoregional recurrence after curative colorectal cancer therapy-a single-center analysis.
Kogler P; Kafka-Ritsch R; Sieb M; Sztankay A; Pratschke J; Zitt M
J Gastrointest Surg; 2014 Nov; 18(11):2026-33. PubMed ID: 25159503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
